HK1109078A1 - Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia - Google Patents

Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Info

Publication number
HK1109078A1
HK1109078A1 HK08103128.1A HK08103128A HK1109078A1 HK 1109078 A1 HK1109078 A1 HK 1109078A1 HK 08103128 A HK08103128 A HK 08103128A HK 1109078 A1 HK1109078 A1 HK 1109078A1
Authority
HK
Hong Kong
Prior art keywords
treating
bronchopulmonary dysplasia
treatment regimen
surfactant treatment
preventing
Prior art date
Application number
HK08103128.1A
Other languages
English (en)
Inventor
Anthony Killian
Christopher Schaber
Robert Segal
Carlos Guardia
Original Assignee
Discovery Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36169079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1109078(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Discovery Lab Inc filed Critical Discovery Lab Inc
Publication of HK1109078A1 publication Critical patent/HK1109078A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
HK08103128.1A 2005-01-06 2008-03-18 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia HK1109078A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64180505P 2005-01-06 2005-01-06
PCT/US2006/000308 WO2006074296A1 (en) 2005-01-06 2006-01-06 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Publications (1)

Publication Number Publication Date
HK1109078A1 true HK1109078A1 (en) 2008-05-30

Family

ID=36169079

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08103128.1A HK1109078A1 (en) 2005-01-06 2008-03-18 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Country Status (14)

Country Link
US (1) US7541331B2 (es)
EP (2) EP2298349A1 (es)
JP (2) JP2008526868A (es)
AT (1) ATE538814T1 (es)
AU (1) AU2006203978B2 (es)
CA (1) CA2593758A1 (es)
CY (1) CY1112769T1 (es)
DK (1) DK1841458T3 (es)
ES (1) ES2380046T3 (es)
HK (1) HK1109078A1 (es)
PL (1) PL1841458T3 (es)
PT (1) PT1841458E (es)
SI (1) SI1841458T1 (es)
WO (1) WO2006074296A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
KR20090060348A (ko) * 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
US7951781B2 (en) * 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
PT2247297T (pt) * 2008-01-31 2019-04-24 Univ Vanderbilt Tratamento terapêutico para estados pulmonares
KR101932831B1 (ko) 2008-01-31 2018-12-27 반더빌트유니버시티 관상과 동맥의 동맥류성 지주막하출혈의 치료를 위한 조성물 및 방법
AU2014204490B2 (en) * 2008-01-31 2016-05-12 Vanderbilt University Therapeutic treatment for lung condtions
US9044392B2 (en) * 2010-03-19 2015-06-02 Wisconsin Alumni Research Foundation Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
WO2017070338A1 (en) * 2015-10-20 2017-04-27 Indiana University Research &Technology Corporation Methods and compositions for treating lung disease of prematurity
PL3558376T3 (pl) * 2016-12-22 2022-02-14 Chiesi Farmaceutici S.P.A. Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD
WO2019206731A1 (en) * 2018-04-23 2019-10-31 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of bpd
KR102173673B1 (ko) * 2018-05-04 2020-11-03 사회복지법인 삼성생명공익재단 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법
US20230097886A1 (en) * 2021-07-30 2023-03-30 Ayuvis Research, Inc. Compositions and methods for the treatment of bronchopulmonary dysplasia (bpd) and bpd-associated pulmonary hypertension

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US502495A (en) 1893-08-01 klijsel
US4659805A (en) 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4918161A (en) 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
IT1203873B (it) 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
JP2602968B2 (ja) 1987-11-04 1997-04-23 カリフォルニア バイオテクノロジー インコーポレイテッド 肺胞の界面活性タンパク類
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US6013619A (en) 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5238920A (en) 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
US5272252A (en) 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
EP0635028B1 (en) 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
US5302481A (en) 1993-06-07 1994-04-12 Xerox Corporation Toner compositions with negative charge enhancing complexes
NZ277095A (en) 1993-12-08 1997-09-22 Tokyo Tanabe Co Peptide that exhibits potent surface activity, lung surfactant containing such and its use in treating respiratory distress syndrome
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5863563A (en) * 1994-10-20 1999-01-26 Alphagene Inc. Treatment of pulmonary conditions associated with insufficient secretion of surfactant
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US6884777B1 (en) * 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
JP2004305006A (ja) * 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
WO2006026237A1 (en) * 2004-05-20 2006-03-09 Discovery Laboratories, Inc. Methods, systems and devices for noninvasive pulmonary delivery
EP1755720A1 (en) * 2004-05-20 2007-02-28 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery

Also Published As

Publication number Publication date
DK1841458T3 (da) 2012-04-23
SI1841458T1 (sl) 2012-04-30
EP1841458B9 (en) 2012-12-12
JP2008526868A (ja) 2008-07-24
JP2013177422A (ja) 2013-09-09
EP1841458B1 (en) 2011-12-28
ATE538814T1 (de) 2012-01-15
PL1841458T3 (pl) 2012-05-31
ES2380046T3 (es) 2012-05-08
EP2298349A1 (en) 2011-03-23
US7541331B2 (en) 2009-06-02
US20060194728A1 (en) 2006-08-31
PT1841458E (pt) 2012-04-10
CY1112769T1 (el) 2016-02-10
WO2006074296A1 (en) 2006-07-13
EP1841458A1 (en) 2007-10-10
AU2006203978B2 (en) 2011-11-03
AU2006203978A1 (en) 2006-07-13
CA2593758A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
HK1109078A1 (en) Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
NL300936I2 (nl) Semaglutide
CY1110353T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
NO20070782L (no) Tetrapeptidanaloger.
CY2015024I1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
NO20072733L (no) Doseformer
EA200702493A1 (ru) Соединения и способы лечения или предотвращения флавивирусных инфекций
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
CY1112790T1 (el) Χρηση μαγιας σεληνιου στην αντιμετωπιση της νοσου αλτσχαιμερ
CY1111489T1 (el) Ενωσεις για την αναστολη του πρωτεασωματος
NO20064732L (no) Alfa-aminoamidderivater nyttige i behandlingen av urolige bein-syndromet og additive lidelser
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
TW200716146A (en) Method for treating or preventing systemic inflammation in formula-fed infants
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
CY1111067T1 (el) Χρηση της ν-(διβενζ (β,f) οξεπιν-10-υλμεθυλ) -ν-μεθυλ-ν-προπ-2-υνυλαμινης (omigapil) στην προληψη και/ή την θεραπεια της μυϊκης δυστροφiας
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
SE0303236L (sv) Förfarande för behandling av aska för gödningsändamål
ATE447018T1 (de) Hochsichere intranasal verabreichbare genimpfstoffe zur behandlung von morbus alzheimer
CY1116330T1 (el) Αναλογα 2-αμινοπυριδινης ως ενεργοποιητες γλυκοκινασης
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases
HK1096379A1 (en) Sulfonamide derivatives for the treatment of diseases
ITMI20051414A1 (it) Formulazioni oftalmiche pere il trattamento e a profilassi della sindrome dell'occhio secco

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190109